Variations in clinical characteristics in underrepresented patients with renal cell carcinoma were investigated. This study included 294 patients and showed Hispanic and Native American patients were more likely to be diagnosed with clear-cell subtype and at a younger age than European American patients. Older Hispanic patients who spoke Spanish were more likely to have advanced stage renal cell carcinoma. Background: Racial/ethnic minority groups, including Hispanic Americans (HAs) and Native Americans (NAs), have a heavier burden of kidney cancer than European Americans (EAs). We investigated variations in clinical characteristics of HA and NA patients with renal cell carcinoma (RCC) who were previously underrepresented. Materials and Methods: Clinical records of 294 patients with RCC (151 EAs, 95 HAs, 22 NAs, and 26 others) without prior diagnosis of cancer were reviewed. Logistic regression analysis was performed to understand patients' clinical characteristics. Results: HAs had about 5 years younger average age at diagnosis than EAs (55.8 vs. 60.5 years) and an almost 3-fold increased odds of diagnosis before age 50 years (odds ratio [OR], 2.77; 95% confidence interval [CI], 1.39-5.54). The mean age of diagnosis among NAs was 49.7 years, and NAs had an over 6-fold higher odds of diagnosis at a younger age (OR, 6.23; 95% CI, 2.00-19.46). Clear-cell RCC (ccRCC) was more common in HAs and NAs than EAs. Over 90% of HA patients had ccRCC, whereas only 78.8% of EA patients had ccRCC. HAs had increased odds of diagnosis with ccRCC compared with EAs (OR, 2.79; 95% CI, 1.15-6.80). Among HAs, older patients and patients who spoke Spanish as their primary language were more likely to have advanced stage RCC at diagnosis (OR, 10.48; 95% CI, 1.69-64.89 and OR, 4.61; 95% CI, 1.38-15.40). Conclusion: HA and NA patients with RCC had different clinical characteristics than EA patients. It is necessary to better understand the clinical characteristics of these underserved HA and NA populations with high kidney cancer burden.
Introduction
Racial/ethnic minority groups, including African Americans (AAs), Hispanic Americans (HAs), and Native Americans (NAs), have a heavier burden of kidney cancer based on higher incidence and mortality rates compared with European Americans (EAs) of non-Hispanic origin. 1, 2 However, it remains unknown why this racial disparity exists. HAs and NAs are underrepresented in clinical and molecular genomic studies of renal cell carcinoma (RCC), and clinical characteristics of RCC among these ethic groups are not well understood. 3 These differences raise the questions of whether racial/ ethnic groups have more aggressive forms of RCC and genetic predisposition, and whether other issues related to health care access and lifestyle factors contribute to these disparities. Previous studies have shown that various risk factors, including male gender, chronic kidney disease, smoking, hypertension, and excess body mass index (BMI), predispose to RCC. 4 One study also indicated that HAs appeared to be diagnosed at younger ages, have greater comorbidities, and present more frequently with clear-cell renal cell carcinoma (ccRCC) compared with EA patients. 5 Furthermore, it is well-known that in the United States, access to health care varies significantly by racial/ethnic groups, and this may explain the differences in cancer-related outcomes owing to treatment barriers.
We sought to determine and compare the clinical and pathologic characteristics among HA, NA, AA, and EA patients with RCC who were treated at the University of Arizona College of Medicine/Banner University Medical Center to better understand the disease burden differences between these racial/ethnic groups in Arizona. Arizona is uniquely located to address kidney cancer health disparities, with a good representation of HAs and NAs. This study particularly focuses on HAs, who are the largest racial/ethnic minority groups in Arizona.
Materials and Methods

Samples
After Institutional Review Board approval, the clinical information of patients with RCC, who underwent robotic, laparoscopic, or open, partial, or radical nephrectomy at the University of Arizona College of Medicine/Banner University Medical Center, Tucson, between 2010 and 2017 (n ¼ 427) was reviewed. A total of 294 patients who were diagnosed with RCC were included to understand the patients' clinical characteristics. We excluded 133 patients who did not have a malignant tumor (but a benign renal mass was removed), who had kidney cancer other than RCC, and who had a prior diagnosis of kidney cancer or other types of cancer ( Figure 1 ). Patient demographics (age at surgery, gender, and race/ethnicity), medical history, and surgical and clinical information (histologic subtype, stage at diagnosis, Fuhrman Grade, tumor size, and presence of necrosis) was obtained from their electronic medical record. The Stage, Size, Grade, and Necrosis (SSIGN) score, a composite score of these 4 clinical assessment measures, 10, 11 was calculated.
Statistical Analysis
The independent sample t test and c 2 test were used to understand patient characteristics. Unconditional logistic regression analysis was performed to identify demographic and clinical factors associated with diagnosis with early age, advanced RCC, diagnosis with ccRCC, and undergoing radical nephrectomy adjusting for relevant variables, such as gender, BMI, comorbidity, and health insurance type. In the final adjusted models, statistically nonsignificant variables (P > .10)
that did not affect the associations (odds ratios [ORs] ) between variables of our interest and outcomes were not included. Patients with metastasis at diagnosis (n ¼ 34) were excluded for analysis of nephrectomy type (radical vs. partial nephrectomy). Sub-analysis with HA patients were performed to identify demographic and clinical factors associated with diagnosis with advanced stage RCC and undergoing radical nephrectomy. Statistical analysis was performed using SPSS v.25 (IBM, Armonk, NY).
Results
The HA (30.3%) and NA (7.7%) patients included in our study reflect Arizona's racial/ethnic composition ( Table 1) . Compared with EAs, HA and NA patients were diagnosed with RCC at a younger age (P < .001). Mean age at diagnosis of HA and NA patients were 55.8 and 49.7 years, respectively, whereas EA patients had mean age of 60.5 years. NA patients had higher BMI than EA patients, and 77.3% of NA patients were obese. Despite the large number of patients who were diagnosed at younger ages, only 6 patients (4 EAs, 1 HA, and 1 NA) self-reported having family history of kidney cancer. Diabetes was more common in HA (45.6%) and NA (54.5%) patients compared with EA (21.7%) patients. A history of cigarette smoking was less common in HA and NA patients. Although it was not statistically significant, a higher proportion of HA and NA patients had public health insurance, such as Medicare and other public health insurance, compared with EA patients.
A RCC histologic subtype, ccRCC, was more common in HAs and NAs than EAs. Over 90% of HA patients had ccRCC, whereas only 78.8% of EA patients had ccRCC. ccRCC was also common among NA patients (86.4%). AA, HA, and NA patients tended to be diagnosed with advanced stage RCC (Stage III or IV). A significantly higher proportion of AA patients (77.8%) were diagnosed with advanced stage RCC and were more likely to receive radical nephrectomy than EA patients. Although not statistically significant, a higher proportion of HA and NA patients were diagnosed with advanced stage RCC when compared with EAs. Renal Cell Carcinoma Disparities Renal 16 .5% and 11.1%, respectively, in HAs and NAs). These differences were not statistically significant. There were 34 (11.6%) patients who had metastatic RCC at diagnosis, and we did not observe a statistically significant difference in the frequency of metastatic RCC across racial/ethnic groups. We performed logistic regression analyses to identify risk factors for diagnosis of RCC at a younger age (< 50 years), and race/ ethnicity and obesity were independently associated with an increased odds of diagnosis at younger age (Table 2) . HAs had almost a 3-fold increased odds of diagnosis before age 50 years (OR, 2.77; 95% confidence interval [CI], 1.39-5.54), and NAs had more than a 6-fold higher odds of diagnosis at a younger age (OR, 6.23; 95% CI, 2.00-19.46). Odds of diagnosis with young age increased with BMI, and morbidly obese patients had almost a 4-fold increased odds of diagnosis with young age (OR, 3.98; 95% CI, 1.24-12.79). Because older patients often had diabetes and hypertension, having diabetes and hypertension was associated with a decreased odds of diagnosis at younger age. A similar pattern was observed when the analysis was performed only for patients with ccRCC.
Logistic regression analysis was performed to identify demographic and clinical characteristics associated with: (1) diagnosis with advanced stage RCC; (2) diagnosis with ccRCC; and (3) undergoing radical nephrectomy rather than partial nephrectomy (Table 3) . Racial/ethnic minority groups were more likely to be diagnosed with advanced stage RCC. AAs had statistically significantly higher odds of diagnosis with advanced RCC, but owing to small sample size, the CI was large (OR, 6.51; 95% CI, 1.28-33.02). Compared with EAs, HAs and NAs had about a 50% increased odds of being diagnosed with advanced RCC, but the associations were not significant. Insurance type was not associated with diagnosis with advanced RCC, and including insurance type and other factors did not change the association. HAs had an increased odds of diagnosis with ccRCC compared with EAs (OR, 2.79; 95% CI, 1.15-6.80). The only factor that predicted radical nephrectomy was stage at diagnosis (OR, 11.59; 95% CI, 5.07-26.51).
Analysis was performed among HA patients to further understand their demographic characteristics related to their diagnosis and surgical care ( had an increased odds of undergoing radical nephrectomy rather than partial nephrectomy (OR, 4.80; 95% CI, 1.71-13.50). After adjusting for relevant variables, the association was attenuated but showed a trend for a statistical significance with P ¼ .08.
Discussion
We examined the variation in clinical and pathologic characteristics across the racial/ethnic groups and demonstrated that RCC health disparities exists among patients with RCC in Arizona. We found that HAs were diagnosed with RCC at a younger age than EA patients. ccRCC histology as well as comorbid conditions (for example, diabetes) were found to be more common among HA patients than EA patients. These findings are in concordance with prior studies about RCC in HAs. 5, 12 Although the analysis results should be treated with caution owing to small sample size, we also found similar characteristics in the NA patients, such as younger age of diagnosis, higher frequency of ccRCC, and higher prevalence of diabetes than EA patients. Moreover, our results suggest that race/ ethnicity and obesity are risk factors independently associated with increased odds of RCC diagnosis at a younger age (< 50 years). The kidney cancer incidence rate has increased over the past decades, especially in the younger age group (< 50 years). 13 The strong associations between obesity and kidney cancer incidence or mortality have been reported previously. 14, 15 The increase in the RCC incidence rate is partly owing to increase in obesity, and a study estimated a 5% increase in RCC incidence risk per 1 kg/m 2 increase in BMI. 16 Racial/ethnic minority groups, including AAs, NA, and United States-born HAs, have higher kidney cancer incidence and mortality rates. 1,2,17 Obesity, diabetes, and hypertension are risk factors for kidney cancer that are potentially causing disparities. Hypertension is not as prevalent in HAs and NAs as in in AAs, and HAs and NAs have a slightly lower hypertension prevalence than EAs. 18 However, obesity is more prevalent among HAs and NAs than EAs. 19, 20 It is possible that obesity affects RCC in HAs and NAs through different biologic mechanisms. The 2014 National Health Interview Survey results show that HAs and NAs have a higher prevalence of diabetes than EAs. 21 Notably, a higher proportion of NAs reported having kidney disease compared with other racial/ethnic groups, and more HAs reported having kidney disease than EAs. Issues related to access to health care or limited health care utilization may also explain the higher kidney cancer burden among racial/ethnic minority groups. We observed a higher proportion of racial/ethnic minority patients diagnosed with advanced stage RCC, and including the insurance type in the regression model did not change the association, suggesting that factors other than insurance affected health care access and utilization among them. A sub-analysis for HA patients was performed to elucidate specific risk factors among this group. Various factors, such as transportation, linguistic and cultural barriers, knowledge on cancer, cultural belief, and mistrust, are known to affect health care access and utilization among racial/ethnic minority groups. 22, 23 In our patients, older HAs and HAs who spoke Spanish were more likely to have advanced RCC at presentation. These older Spanishspeaking HAs may have had reduced access to health care or reduced health care utilization, which led to a diagnosis with advanced stage RCC. Regardless of the surgical approach (laparoscopic/robotic vs. open), obese patients represent a surgical challenge. However, several studies have demonstrated the feasibility of performing nephron-sparing surgery or utilization of minimally invasive techniques in obese patients without any significant adverse outcomes when compared with non-obese patients. [24] [25] [26] Currently, criteria to decide whether a patient is a candidate for nephron-sparing surgery versus radical nephrectomy is based on tumor characteristics and not on BMI. The association between BMI and radical nephrectomy in this study probably reflects the academic setting of our institution where challenging cases are routinely referred. Given the high proportion of obese patients as well as obese individuals in racial/ ethnic groups, special attention should be given to these patients when counseling for surgical treatments.
There are several limitations of this study. First, patients are from a single academic hospital in southern Arizona, so our findings may not be generalizable. There may be patients with complicated cases of RCC (eg, obese patients or patients with multiple comorbid conditions) referred to our hospital. Second, this is a retrospective study reviewing patients' medical records. There was some missing information, and accuracy of information, such as race/ethnicity and family history of kidney cancer, could not be assessed. Third, sample size was very small for some racial/ethnic groups, such as NAs and AAs. A sub-analysis was also performed for a small group of HA patients. Confidence intervals were often too large, and the statistical analysis results should be treated with caution. Finally, there was limited data available in patients' clinical records to assess lifestyle (eg, diet and physical exercise), health care access (eg, geographic distance and personal finance), and environmental (eg, exposure to environmental toxins or occupational exposures) factors associated with clinical characteristics. Multi-institutional studies including more patients and comparing lifestyle, environmental, and genetic factors between the different racial groups will validate our findings and provide information to assess the causes of kidney cancer health disparities.
Conclusion
NA and HA patients have some different clinical characteristics than EA patients. NA and HA patients were diagnosed with RCC at younger age, and they are more likely to have ccRCC than EA patients. Diabetes was found to be more common among NA and HA patients with RCC than EA patients. However, the causes for RCC health disparities is still not clear, and additional analysis is necessary.
Clinical Practice Points
RCC is the 6th most common cancer in men in the United States and the 10th most common in women in the United States. The American Cancer Society estimates that in 2018 there will be 65,340 cases (42,680 in males and 22,660 in females) of RCC with approximately 14,970 deaths. It is necessary to identify the populations at higher risk for RCC mortality and health care issues that lead to poor survival and outcomes in the high-risk populations to intervene and potentially decrease the mortality. Previous studies have identified racial/ethnic minority groups, including AAs, HAs, and NAs, that had a heavier kidney cancer burden compared with EAs. In our study, we found that the onset varies among racial/ethnic groups. We found that HA and NA patients were diagnosed at a younger age compared with EA patients. In logistic regression analysis, race/ethnicity and obesity were independent risk factors for diagnosis of RCC at a younger age. Similarly, our results also indicate that minority groups, including HAs and NAs, were more likely to have comorbidity and be diagnosed with advanced RCC compared with EA patients. Our findings can direct future research towards elucidating the difference in tumor behavior among the different ethnic groups and health care issues causing poor outcomes. It also brings awareness to practitioners treating patients from these racial/ ethnic minority groups regarding the clinical characteristics and underlying issues in these patient populations.
